Investor presentation demonstrating countries of sales shows significant room for growth in the US.I'm assuming the recent profit upgrade is based on normal revenues, not any abnormal items?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025